Search

everythinglearnresearchcommunity

for

Search:↓

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Sunekos® effectively improves labia majora appearance and is well-tolerated.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Angiopteris evecta extracts significantly promote hair growth in rabbits.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Spironolactone most effective for hirsutism, but has side effects.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

SHBG may be a useful early indicator and treatment target for PCOS.

Spironolactone helps regrow hair in women with hair loss.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.